JP2010502759A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010502759A5 JP2010502759A5 JP2009527791A JP2009527791A JP2010502759A5 JP 2010502759 A5 JP2010502759 A5 JP 2010502759A5 JP 2009527791 A JP2009527791 A JP 2009527791A JP 2009527791 A JP2009527791 A JP 2009527791A JP 2010502759 A5 JP2010502759 A5 JP 2010502759A5
- Authority
- JP
- Japan
- Prior art keywords
- motomeko
- active ingredient
- composition
- cytokines
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- 239000000126 substance Substances 0.000 claims 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 6
- 102000004127 Cytokines Human genes 0.000 claims 5
- 108090000695 Cytokines Proteins 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 5
- 229940124597 therapeutic agent Drugs 0.000 claims 5
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 4
- 239000008187 granular material Substances 0.000 claims 4
- 230000000968 intestinal effect Effects 0.000 claims 4
- 239000003826 tablet Substances 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 3
- 208000015943 Coeliac disease Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 241000792859 Enema Species 0.000 claims 2
- 102000014150 Interferons Human genes 0.000 claims 2
- 108010050904 Interferons Proteins 0.000 claims 2
- 102000015696 Interleukins Human genes 0.000 claims 2
- 108010063738 Interleukins Proteins 0.000 claims 2
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 210000001072 colon Anatomy 0.000 claims 2
- 239000007920 enema Substances 0.000 claims 2
- 229940079360 enema for constipation Drugs 0.000 claims 2
- 239000006260 foam Substances 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 229940047122 interleukins Drugs 0.000 claims 2
- 239000008188 pellet Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 239000008247 solid mixture Substances 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 239000000829 suppository Substances 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 102000003390 tumor necrosis factor Human genes 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims 1
- 241001529936 Murinae Species 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 230000000973 chemotherapeutic effect Effects 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000001842 enterocyte Anatomy 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 230000004968 inflammatory condition Effects 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 210000000664 rectum Anatomy 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20061741 ITMI20061741A1 (it) | 2006-09-12 | 2006-09-12 | Composizioni farmaceutiche per la somministrazione orale di sostanze proteiche |
| ITMI20071205 ITMI20071205A1 (it) | 2007-06-15 | 2007-06-15 | Composizioni farmaceutiche per la somministrazione orale o rettale di sostanze proteiche |
| PCT/EP2007/059378 WO2008031770A2 (en) | 2006-09-12 | 2007-09-07 | Pharmaceutical compositions for the oral or rectal administration of protein substances |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010502759A JP2010502759A (ja) | 2010-01-28 |
| JP2010502759A5 true JP2010502759A5 (https=) | 2010-10-21 |
Family
ID=39107203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009527791A Pending JP2010502759A (ja) | 2006-09-12 | 2007-09-07 | タンパク質物質の経口または直腸投与のための医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100004157A1 (https=) |
| EP (1) | EP2081555A2 (https=) |
| JP (1) | JP2010502759A (https=) |
| KR (1) | KR20090086060A (https=) |
| CA (1) | CA2663548A1 (https=) |
| MX (1) | MX2009002756A (https=) |
| RU (1) | RU2009113557A (https=) |
| WO (1) | WO2008031770A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12203056B2 (en) | 2008-03-28 | 2025-01-21 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
| US8809392B2 (en) | 2008-03-28 | 2014-08-19 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
| GB201017048D0 (en) * | 2010-10-08 | 2010-11-24 | Ucl Business Plc | Composition |
| US10946091B2 (en) * | 2012-06-04 | 2021-03-16 | Gaurav Agrawal | Compositions and methods for treating Crohn's disease and related conditions and infections |
| EP3142645A4 (en) * | 2014-05-15 | 2017-12-27 | Rani Therapeutics, LLC | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| US11548940B2 (en) | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| WO2016156468A1 (en) | 2015-03-31 | 2016-10-06 | Vhsquared Limited | Polypeptides |
| HK1250011A1 (zh) | 2015-03-31 | 2018-11-23 | Sorriso Pharmaceuticals, Inc. | 具有蛋白酶可切割接头的肽构建体 |
| AU2016257813B2 (en) * | 2015-05-01 | 2021-05-13 | Rani Therapeutics, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| AU2016261599B2 (en) * | 2015-05-08 | 2021-08-26 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| JP7224917B2 (ja) * | 2016-03-31 | 2023-02-20 | ソリッソ ファーマシューティカルズ，インク． | 組成物 |
| US11491114B2 (en) | 2016-10-12 | 2022-11-08 | Curioralrx, Llc | Formulations for enteric delivery of therapeutic agents |
| CA3045310A1 (en) * | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| EP3501503A1 (en) * | 2017-12-22 | 2019-06-26 | Cosmo Technologies Ltd. | Solid delivery composition |
| WO2020254827A1 (en) | 2019-06-21 | 2020-12-24 | Vhsquared Limited | Polypeptides |
| JP7680377B2 (ja) | 2019-06-21 | 2025-05-20 | ソリッソ ファーマシューティカルズ，インク． | ポリペプチド |
| KR20220063148A (ko) | 2019-06-21 | 2022-05-17 | 소리소 파마슈티컬스 인크. | 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99120A0 (en) * | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| AU698393B2 (en) * | 1994-06-24 | 1998-10-29 | Immunex Corporation | Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| EP1183014B1 (en) * | 1999-06-14 | 2003-10-08 | Cosmo S.p.A. | Controlled release and taste masking oral pharmaceutical compositions |
| JP2005510542A (ja) * | 2001-11-30 | 2005-04-21 | ファイザー・プロダクツ・インク | 炎症の治療のための、ｉｌ−１／１８阻害剤及びｔｎｆ阻害剤の組み合わせ。 |
| ITMI20012599A1 (it) * | 2001-12-11 | 2003-06-11 | Cosmo Spa | Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int |
| EA200600598A1 (ru) * | 2003-09-19 | 2006-08-25 | Пенвест Фармасьютикалз Ко. | Лекарственные формы замедленного высвобождения |
| WO2006009764A1 (en) * | 2004-06-17 | 2006-01-26 | Amano Enzyme Usa., Ltd. | Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| US7879361B2 (en) * | 2005-01-04 | 2011-02-01 | Gp Medical, Inc. | Nanoparticles for drug delivery |
| DE602006020123D1 (de) * | 2005-05-04 | 2011-03-31 | Zealand Pharma As | Glucagon-like-peptide-2- (glp-2-) analoga |
-
2007
- 2007-09-07 WO PCT/EP2007/059378 patent/WO2008031770A2/en not_active Ceased
- 2007-09-07 MX MX2009002756A patent/MX2009002756A/es not_active Application Discontinuation
- 2007-09-07 US US12/441,112 patent/US20100004157A1/en not_active Abandoned
- 2007-09-07 EP EP07803323A patent/EP2081555A2/en not_active Withdrawn
- 2007-09-07 RU RU2009113557/15A patent/RU2009113557A/ru not_active Application Discontinuation
- 2007-09-07 KR KR1020097007396A patent/KR20090086060A/ko not_active Withdrawn
- 2007-09-07 JP JP2009527791A patent/JP2010502759A/ja active Pending
- 2007-09-07 CA CA002663548A patent/CA2663548A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010502759A5 (https=) | ||
| RU2009113557A (ru) | Фармацевтические композиции для перорального или ректального введения белковых веществ | |
| Chen et al. | CCL20 signaling in the tumor microenvironment | |
| ES2771458T3 (es) | Formulación de combinación de dos compuestos antivirales | |
| ES2745479T3 (es) | Combinación que comprende un inhibidor de MEK y un inhibidor de B-raf | |
| JP5926243B2 (ja) | 経口薬物療法のための方法および組成物 | |
| ES2553897T3 (es) | El uso de partículas de vehículo sólido para mejorar la procesabilidad de un agente farmacéutico | |
| ES2822665T3 (es) | Terapias de combinación para el cáncer | |
| ES2913494T3 (es) | Composiciones de forma farmacéutica que comprenden un inhibidor de tirosina cinasa de Bruton | |
| JP2008507536A5 (https=) | ||
| JP2020510662A5 (https=) | ||
| HRP20161329T1 (hr) | Oralni oblici doziranja koji sadrže likarbazepin acetat | |
| BRPI0715247A2 (pt) | forma farmacÊutica com camada de separaÇço de méltiplas camadas | |
| JP2019529476A5 (https=) | ||
| JP2023536094A (ja) | 新規の胃内滞留性持続放出剤形 | |
| JP2017031209A (ja) | アタシセプトなどのＴＡＣＩ−Ｉｇ融合タンパク質を用いた自己免疫疾患を治療するための投薬法 | |
| ES2870562T3 (es) | Composiciones y procedimientos para el tratamiento del crecimiento celular anormal | |
| JPWO2021155264A5 (https=) | ||
| KR101648490B1 (ko) | 위체류 약물 전달시스템을 이용한 서방성 경구용 제제 | |
| JP2021510677A5 (https=) | ||
| US7538094B2 (en) | Composition containing ribavirin and use thereof | |
| CN102770026B (zh) | 组合 | |
| HK1223547A1 (zh) | 癌症治疗方法 | |
| EP2571358A1 (en) | Combination | |
| JP2010504969A (ja) | Ｓａｈａのアミン塩基塩及びその多形 |